Metastatic Prostate Cancer Treatment Market Report

Global and China Metastatic Prostate Cancer Treatment Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 07, 2022
  • PAGES：163
  • REPORT CODE：GMM1442270
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Metastatic Prostate Cancer Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • AB Science

    • SeleXel

    • Genentech

    • Immunomedics(Gilead Sciences Inc)

    • BeiGene

    • Zenith Epigenetics Ltd

    • Myovant Biosciences

    • eFFECTOR Therapeutics

    • Arvinas Inc

    • Amgen

    • VasGene Therapeutics Inc

    • Telix Pharmaceuticals

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Mono

    • Combination

    • Mono/Combination

    Application:

    • Hospital

    • Drug Store

    • Online Pharmacy

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Metastatic Prostate Cancer Treatment Industry Overview

      • 1.1.1 Metastatic Prostate Cancer Treatment Market Scope and Market Segments

      • 1.1.2 Metastatic Prostate Cancer Treatment Industry Characteristics

      • 1.1.3 Global and China Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Metastatic Prostate Cancer Treatment Production Value and Growth Rate (2017-2028)

    • 1.2 Global Metastatic Prostate Cancer Treatment Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Mono

      • 1.2.2 Combination

      • 1.2.3 Mono/Combination

    • 1.3 Global Metastatic Prostate Cancer Treatment Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Drug Store

      • 1.3.3 Online Pharmacy

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Metastatic Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Metastatic Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Metastatic Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Metastatic Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Metastatic Prostate Cancer Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Metastatic Prostate Cancer Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Metastatic Prostate Cancer Treatment Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Metastatic Prostate Cancer Treatment Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Metastatic Prostate Cancer Treatment Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Metastatic Prostate Cancer Treatment Industry Porter's Five Forces Model Analysis

      • 2.2.3 Metastatic Prostate Cancer Treatment Industry PEST Analysis

    • 2.3 Metastatic Prostate Cancer Treatment Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Metastatic Prostate Cancer Treatment Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Metastatic Prostate Cancer Treatment Industry

    Chapter 3 Global and China Metastatic Prostate Cancer Treatment Market, by Manufacturer

    • 3.1 Global and China Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Metastatic Prostate Cancer Treatment Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Metastatic Prostate Cancer Treatment Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Metastatic Prostate Cancer Treatment Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Metastatic Prostate Cancer Treatment Market Top 3 Players

    Chapter 4 Global and China Metastatic Prostate Cancer Treatment Market, by Type (2017-2028)

    • 4.1 Metastatic Prostate Cancer Treatment Market Trend, by Type

    • 4.2 Global Metastatic Prostate Cancer Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Metastatic Prostate Cancer Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Metastatic Prostate Cancer Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Metastatic Prostate Cancer Treatment Price Trend, by Type (2017-2028)

    • 4.3 China Metastatic Prostate Cancer Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Metastatic Prostate Cancer Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Metastatic Prostate Cancer Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Metastatic Prostate Cancer Treatment Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Metastatic Prostate Cancer Treatment Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Metastatic Prostate Cancer Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Metastatic Prostate Cancer Treatment Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Metastatic Prostate Cancer Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Metastatic Prostate Cancer Treatment Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Metastatic Prostate Cancer Treatment Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Metastatic Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Metastatic Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Metastatic Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Metastatic Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Metastatic Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Metastatic Prostate Cancer Treatment Market Analysis

    • 7.1 North America Metastatic Prostate Cancer Treatment Market, by Type

    • 7.2 North America Metastatic Prostate Cancer Treatment Market, by Application

    • 7.3 North America Metastatic Prostate Cancer Treatment Market Analysis and Forecast, by Country

      • 7.3.1 United States Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Metastatic Prostate Cancer Treatment Market Analysis

    • 8.1 Europe Metastatic Prostate Cancer Treatment Market, by Type

    • 8.2 Europe Metastatic Prostate Cancer Treatment Market, by Application

    • 8.3 Europe Metastatic Prostate Cancer Treatment Market Analysis and Forecast, by Country

      • 8.3.1 Germany Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Metastatic Prostate Cancer Treatment Market Analysis

    • 9.1 APAC Metastatic Prostate Cancer Treatment Market, by Type

    • 9.2 APAC Metastatic Prostate Cancer Treatment Market, by Application

    • 9.3 APAC Metastatic Prostate Cancer Treatment Market Analysis and Forecast, by Country

      • 9.3.1 China Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Metastatic Prostate Cancer Treatment Market Analysis

    • 10.1 Latin America, Middle East and Africa Metastatic Prostate Cancer Treatment Market, by Type

    • 10.2 Latin America, Middle East and Africa Metastatic Prostate Cancer Treatment Market, by Application

    • 10.3 Latin America, Middle East and Africa Metastatic Prostate Cancer Treatment Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Metastatic Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Metastatic Prostate Cancer Treatment Company Profiles

      • 11.1 AB Science

        • 11.1.1 AB Science Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 AB Science Metastatic Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.1.3 AB Science Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 SeleXel

        • 11.2.1 SeleXel Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 SeleXel Metastatic Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.2.3 SeleXel Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Genentech

        • 11.3.1 Genentech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Genentech Metastatic Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.3.3 Genentech Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Immunomedics(Gilead Sciences Inc)

        • 11.4.1 Immunomedics(Gilead Sciences Inc) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Immunomedics(Gilead Sciences Inc) Metastatic Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.4.3 Immunomedics(Gilead Sciences Inc) Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 BeiGene

        • 11.5.1 BeiGene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 BeiGene Metastatic Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.5.3 BeiGene Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Zenith Epigenetics Ltd

        • 11.6.1 Zenith Epigenetics Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Zenith Epigenetics Ltd Metastatic Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.6.3 Zenith Epigenetics Ltd Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Myovant Biosciences

        • 11.7.1 Myovant Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Myovant Biosciences Metastatic Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.7.3 Myovant Biosciences Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 eFFECTOR Therapeutics

        • 11.8.1 eFFECTOR Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.8.3 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Arvinas Inc

        • 11.9.1 Arvinas Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Arvinas Inc Metastatic Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.9.3 Arvinas Inc Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Amgen

        • 11.10.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Amgen Metastatic Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.10.3 Amgen Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 VasGene Therapeutics Inc

        • 11.11.1 VasGene Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 VasGene Therapeutics Inc Metastatic Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.11.3 VasGene Therapeutics Inc Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Telix Pharmaceuticals

        • 11.12.1 Telix Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.12.3 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Metastatic Prostate Cancer Treatment Industry Investment Prospect and Risk Assessment

    • 12.1 Metastatic Prostate Cancer Treatment Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Metastatic Prostate Cancer Treatment Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Global Metastatic Prostate Cancer Treatment Production Value and Growth Rate (2017-2028)

    • Figure China Metastatic Prostate Cancer Treatment Production Value and Growth Rate (2017-2028)

    • Figure Global Metastatic Prostate Cancer Treatment Market Size and Growth Rate of Mono (2017-2028)

    • Figure Global Metastatic Prostate Cancer Treatment Market Size and Growth Rate of Combination (2017-2028)

    • Figure Global Metastatic Prostate Cancer Treatment Market Size and Growth Rate of Mono/Combination (2017-2028)

    • Figure Global Metastatic Prostate Cancer Treatment Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Metastatic Prostate Cancer Treatment Market Size and Growth Rate of Drug Store (2017-2028)

    • Figure Global Metastatic Prostate Cancer Treatment Market Size and Growth Rate of Online Pharmacy (2017-2028)

    • Figure North America Metastatic Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Metastatic Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Metastatic Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Metastatic Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Metastatic Prostate Cancer Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Metastatic Prostate Cancer Treatment Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Metastatic Prostate Cancer Treatment Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Metastatic Prostate Cancer Treatment Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Metastatic Prostate Cancer Treatment Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Metastatic Prostate Cancer Treatment Market Share, by Manufacturer in 2021

    • Figure Global and China Metastatic Prostate Cancer Treatment Market Share, by Manufacturer in 2022

    • Table Global Metastatic Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table Global Metastatic Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Global Metastatic Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table Global Metastatic Prostate Cancer Treatment Sales Value, by Type (2017-2028)

    • Table Global Metastatic Prostate Cancer Treatment Sales Value Share, by Type (2017-2028)

    • Figure Global Metastatic Prostate Cancer Treatment Price Trend, by Type (2017-2028)

    • Table China Metastatic Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table China Metastatic Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure China Metastatic Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table China Metastatic Prostate Cancer Treatment Sales Value, by Type (2017-2028)

    • Table China Metastatic Prostate Cancer Treatment Sales Value Share, by Type (2017-2028)

    • Figure China Metastatic Prostate Cancer Treatment Price Trend, by Type (2017-2028)

    • Table Global Metastatic Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table Global Metastatic Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Global Metastatic Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Table Global Metastatic Prostate Cancer Treatment Sales Value, by Application (2017-2028)

    • Table Global Metastatic Prostate Cancer Treatment Sales Value Share, by Application (2017-2028)

    • Figure Global Metastatic Prostate Cancer Treatment Sales Value Share, by Application (2017-2028)

    • Table China Metastatic Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table China Metastatic Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Metastatic Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Table China Metastatic Prostate Cancer Treatment Sales Value, by Application (2017-2028)

    • Table China Metastatic Prostate Cancer Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Metastatic Prostate Cancer Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Metastatic Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure North America Metastatic Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Metastatic Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Metastatic Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Metastatic Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • Table North America Metastatic Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table North America Metastatic Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure North America Metastatic Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table North America Metastatic Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table North America Metastatic Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure North America Metastatic Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure United States Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure United States Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Canada Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Table Europe Metastatic Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table Europe Metastatic Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Europe Metastatic Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table Europe Metastatic Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table Europe Metastatic Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Europe Metastatic Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Germany Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure UK Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure UK Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure France Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure France Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Italy Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Spain Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Poland Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Russia Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Table APAC Metastatic Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table APAC Metastatic Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure APAC Metastatic Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table APAC Metastatic Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table APAC Metastatic Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure APAC Metastatic Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Japan Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure India Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure India Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Metastatic Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Metastatic Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Metastatic Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Metastatic Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Metastatic Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Metastatic Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Metastatic Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Metastatic Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Table AB Science Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AB Science Product Profiles, Application and Specification

    • Table AB Science Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table SeleXel Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table SeleXel Product Profiles, Application and Specification

    • Table SeleXel Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genentech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genentech Product Profiles, Application and Specification

    • Table Genentech Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Immunomedics(Gilead Sciences Inc) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Immunomedics(Gilead Sciences Inc) Product Profiles, Application and Specification

    • Table Immunomedics(Gilead Sciences Inc) Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BeiGene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BeiGene Product Profiles, Application and Specification

    • Table BeiGene Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Zenith Epigenetics Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Zenith Epigenetics Ltd Product Profiles, Application and Specification

    • Table Zenith Epigenetics Ltd Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Myovant Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Myovant Biosciences Product Profiles, Application and Specification

    • Table Myovant Biosciences Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table eFFECTOR Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table eFFECTOR Therapeutics Product Profiles, Application and Specification

    • Table eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Arvinas Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Arvinas Inc Product Profiles, Application and Specification

    • Table Arvinas Inc Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen Product Profiles, Application and Specification

    • Table Amgen Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table VasGene Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table VasGene Therapeutics Inc Product Profiles, Application and Specification

    • Table VasGene Therapeutics Inc Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Telix Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Telix Pharmaceuticals Product Profiles, Application and Specification

    • Table Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US